表紙
市場調查報告書

美國和中國貿易戰爭對醫療保健產業的影響

News Alert-US-China Tariff War Implication for Healthcare Industry

出版商 Frost & Sullivan 商品編碼 918065
出版日期 內容資訊 英文 34 Pages
商品交期: 最快1-2個工作天內
價格
美國和中國貿易戰爭對醫療保健產業的影響 News Alert-US-China Tariff War Implication for Healthcare Industry
出版日期: 2019年11月22日內容資訊: 英文 34 Pages
簡介

本報告提供美國和中國貿易戰爭帶給醫療保健產業的影響相關調查,貿易戰爭的時間軸與引發衝突的東西,新的關稅制度包含美國醫療技術相關的考察,對醫療圖像、醫療設備、醫療診斷產業的影響和健康護理系統的影響效果等相關彙整。

摘要整理

美國和中國貿易戰爭:時間軸、發展

  • 美國和中國貿易戰爭的時間軸
  • 引起關稅交戰的是什麼?
  • 美國新的關稅制度下醫療技術包含的為何?
  • 中國的美國商務的機會及威脅

美國和中國貿易戰爭:主要的影響、策略性要務

  • 對醫療圖像產業的影響
  • 對醫療設備、診斷產業的影響
  • 對醫療圖像、技術產業的影響
  • 影響效果:對健康護理系統的影響
  • 方案分析:下個適當的替代方案
  • 免責聲明

附錄

目錄
Product Code: 9AB9/C2

Better Understand the Timeline of the Tariff War and What Triggered the Hostilities

As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (MedTech) is included in the United States' new tariff policy.

The United States is the world's largest medical technology importer, and China is its fourth-largest supplier. The tariff war is anticipated to create a ripple effect that will impact healthcare systems as costs rise. An unanswered question is who eventually absorbs the increase in costs of medical devices.

Frost & Sullivan's analysis suggests that manufacturers may absorb the costs for high-value medical devices, such as MRI and CT machines, passing some of those costs on to hospitals. For low-end products, especially consumables, customers will end up paying more.

Given the massive growth opportunity with China's domestic market, the tariff war is not going to impact the planned investments of US companies in the Chinese MedTech industry. However, an uneven playing field favoring domestic companies over foreign ones can abate long-term optimism for the Chinese market. About 80% of US origin businesses operations in China indicated that the uneven playing field favoring domestic companies over foreign ones is making it increasingly difficult for US companies to compete in the Chinese market.

Tariffs at both points of the supply chain (in the United States and in China) run the risk of cost inflation for the companies that have manufacturing units in either country, which may eventually lead to an escalation in patient care costs across many countries. As a consequence of the US tariffs on China, other low-cost manufacturing destinations such as Malaysia, Vietnam, and Costa Rica will see a moderate increase in manufacturing activity with some companies expected to shift operations to these destinations. It is critical for US MedTech OEMs to evaluate the total cost of ownership as they examine alternative sourcing destinations. Additional regulatory considerations, such as FDA requirement for the supplemental submission for supplier change affecting changes to input could lead to delays of several months.

Frost & Sullivan finds that next year's presidential election in the United States will be pivotal to the future of the ongoing US-China tariff war. Not surprisingly, healthcare is highly debated political issue. With the anticipated price transparency rules to take effect during 2020, dealing with the US-China tariff related inflation for the US healthcare industry will be a high-priority agenda for the newly elected president.

This Frost Perspective will help:

  • Better understand the timeline of the tariff war and what triggered the battle.
  • Gain insight into why the United States included MedTech under the new tariff regime.
  • Learn about the implications for the medical imaging, medical devices, and diagnostics industries and the ripple effect for healthcare systems.

Table of Contents

Executive Summary

  • Key Findings
  • Research Scope
  • Top 5 Takeaways-Future Outlook for US-China MedTech Industries

US-China Tariff War-Timeline and Developments

  • Timeline of US-China Tariff War
  • What Triggered the Tariff Slugfest?
  • Why did the United States Include Medical Technology Under the New Tariff Regime?
  • Opportunities and Threats for US Businesses in China

US-China Tariff War-Key Implications and Strategic Imperatives

  • Implication for the Medical Imaging Industry
  • Implication for Medical Devices and Diagnostics Industry
  • Implication for Medical Imaging and Technology Industry
  • Ripple Effect-Implication for Healthcare Systems?
  • Scenarios Analysis-Next Right-shoring Alternatives
  • Legal Disclaimer

Appendix

  • US 301 Final List 1
  • US 301 Final List 1 (continued)
  • US 301 Final List 1 (continued)
  • US 301 Final List 3
  • US 301 Final List 4A
  • US 301 Final List 4B
  • List of Exhibits

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence